EODData

SHE, 000403: Pacific Shuanglin Bio pharmacy Co Ltd

02 Sep 2026
LAST:

10.21

CHANGE:
 0.20
OPEN:
10.41
HIGH:
10.42
ASK:
0.00
VOLUME:
5.9M
CHG(%):
1.92
PREV:
10.41
LOW:
10.17
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
02 Sep 2610.4110.4210.1710.215.9M
01 Sep 2610.4310.5210.3510.415.57M
31 Aug 2610.5410.5610.3310.427.79M
28 Aug 2610.7410.7410.5510.594.89M
27 Aug 2610.9510.9710.6510.678.69M
26 Aug 2610.9811.2110.8610.9812.16M
25 Aug 2610.2511.0310.2410.9818.05M
24 Aug 2610.6010.6110.2610.269.91M
21 Aug 2610.9510.9610.6210.6315.12M
20 Aug 2610.8711.2810.8711.0418.95M

PROFILE

Name:Pacific Shuanglin Bio pharmacy Co Ltd
About:Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in research, development, production, and sales of blood products in China. Its lead products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin (PH4), hepatitis B human immunoglobulin, tetanus human immunoglobulin, rabies patient immunoglobulin, and human coagulation factor. addition, it engages in the investment, consultation, and technology promotion of pharmaceutical and biotechnology development projects; and electronic product information consultation. The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021. Pacific Shuanglin Bio-pharmacy Co., Ltd. was founded in 1993 and is based in Taiyuan, China.
Sector:Healthcare
Industry:Biotechnology
Address:Sunshine City Global Financial Center, Taiyuan, China, 030000
Website:https://www.slbiop.com
ISIN:CNE000000F14

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:29.84 
Forward P/E:10.33 
PEG Ratio:-0.38 
Price to Sales:4.03 
Price to Book:1.29 
Profit Margin:0.14 
Operating Margin:0.06 
Return on Assets:0.03 
Return on Equity:0.04 
DivYield:0.01 
Div/Share:0.27 
Revenue:2.601B 
EBITDA:552.47M 
Shares:950.4M 
Market Cap:9.704B 

TECHNICAL INDICATORS

MA5:10.462.4%
MA10:10.624.0%
MA20:10.704.8%
MA50:10.041.7%
MA100:10.997.7%
MA200:12.5523.0%
RSI14:34.62 
WPR14:-100.00 
MTM14:-0.69
ROC14:-0.06 
ATR:0.38 
Week High:11.219.8%
Week Low:10.170.4%
Month High:11.7715.3%
Month Low:10.1723.0%
Year High:18.5281.4%
Year Low:8.5419.6%

RECENT SPLITS

Date Ratio
04 Jun 20251.3-1
27 Jul 20201-1

RECENT DIVIDENDS

Date Amount
04 Jun 2025$0.21
17 Dec 2024$0.09
28 Jun 2024$0.12
20 Jul 2023$0.05
15 Jul 2022$0.03